Owners and management
CVR: 45786684
Secondary names: Luvalis ApS, Luvalis Tech ApS
Not available
Mixin ApS (33,33-49,99%), Ragdoll Invest ApS (33,33-49,99%)
1 more
CVR · view owners
Mikkel Geertsen, Bo Yde Svendsen
1 more in management
Board: Bo Yde Svendsen (chair) and 2 members
CVR · view management
Active
Founded 23 July 2025
CVR · view overview
1 employee
CVR · 2026
Name registered: Luvalis Pharma ApS
CVR · 23/07/2025
View the full event history
Luvalis Pharma ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2025. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mikkel Geertsen, Bo Yde Svendsen and Jonas Hammershaimb Mosbech. The board consists of Bo Yde Svendsen (chair), Jonas Hammershaimb Mosbech and Mikkel Geertsen. The company is owned by Mixin ApS, Ragdoll Invest ApS and BOSV ApS. The company has 1 employee (2026).
Selskabets formål er at drive virksomhed inden for udvikling, produktion og salg af farmaceutiske produkter samt hermed beslægtet virksomhed.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Luvalis Pharma ApS is 45786684.
Luvalis Pharma ApS is owned by Mixin ApS, Ragdoll Invest ApS and BOSV ApS.
The management of Luvalis Pharma ApS consists of Mikkel Geertsen, Bo Yde Svendsen and Jonas Hammershaimb Mosbech.
The board of Luvalis Pharma ApS consists of Bo Yde Svendsen, Jonas Hammershaimb Mosbech and Mikkel Geertsen, with Bo Yde Svendsen as chair.
Luvalis Pharma ApS had 1 employee in 2026 according to the Danish CVR register.
Luvalis Pharma ApS was founded on 23 July 2025.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 51885722, new email: [email protected] (August 20, 2026).
Address changed to Njalsgade 21F 2. 21, 2, 2300 København S (March 9, 2026).
Contact info changed: new phone: 51885722, new email: [email protected] (March 9, 2026).
As of July 23, 2025, Mikkel Geertsen has joined the board of directors of Luvalis Pharma ApS.
As of July 23, 2025, Jonas Hammershaimb Mosbech has joined the board of directors of Luvalis Pharma ApS.
As of July 23, 2025, Bo Yde Svendsen has joined the board of directors of Luvalis Pharma ApS.
As of July 23, 2025, Mikkel Geertsen is registered as adm. dir. of Luvalis Pharma ApS.
As of July 23, 2025, Jonas Hammershaimb Mosbech is registered as director of Luvalis Pharma ApS.
As of July 23, 2025, Bo Yde Svendsen is registered as director of Luvalis Pharma ApS.
As of July 23, 2025, Mixin ApS is registered as an owner of Luvalis Pharma ApS with an ownership share of 33%.
As of July 23, 2025, Ragdoll Invest ApS is registered as an owner of Luvalis Pharma ApS with an ownership share of 33%.
As of July 23, 2025, BOSV ApS is registered as an owner of Luvalis Pharma ApS with an ownership share of 33%.
Luvalis Pharma ApS was founded on July 23, 2025.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 43134477
CVR 36980222
CVR 42790516
CVR 45430324
CVR 34668272
